BioLineRx (BLRX) Receivables - Net (2023 - 2025)

BioLineRx has reported Receivables - Net over the past 3 years, most recently at $46000.0 for Q4 2025.

  • Quarterly results put Receivables - Net at $46000.0 for Q4 2025, down 98.14% from a year ago — trailing twelve months through Dec 2025 was $46000.0 (down 98.14% YoY), and the annual figure for FY2025 was $46000.0, down 98.14%.
  • Receivables - Net for Q4 2025 was $46000.0 at BioLineRx, down from $2.5 million in the prior quarter.
  • Over the last five years, Receivables - Net for BLRX hit a ceiling of $2.5 million in Q4 2024 and a floor of $46000.0 in Q4 2025.
  • Median Receivables - Net over the past 3 years was $358000.0 (2023), compared with a mean of $960000.0.
  • Biggest five-year swings in Receivables - Net: skyrocketed 591.62% in 2024 and later tumbled 98.14% in 2025.
  • BioLineRx's Receivables - Net stood at $358000.0 in 2023, then skyrocketed by 591.62% to $2.5 million in 2024, then tumbled by 98.14% to $46000.0 in 2025.
  • The last three reported values for Receivables - Net were $46000.0 (Q4 2025), $2.5 million (Q4 2024), and $358000.0 (Q4 2023) per Business Quant data.